| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidase activity | CPA6 ADAM23 USP24 MMP21 CPA1 IDE USP37 CFI ADAM22 YOD1 USP8 KLK4 UNC5CL LPA AFG3L2 ADAMTS16 C1R OTULINL PLG ALG13 | 1.66e-06 | 654 | 178 | 20 | GO:0008233 |
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 2.37e-05 | 7 | 178 | 3 | GO:0034988 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 3.25e-05 | 21 | 178 | 4 | GO:0034987 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ADAM23 MMP21 IDE USP37 CFI ADAM22 USP8 KLK4 LPA AFG3L2 ADAMTS16 C1R PLG | 1.33e-04 | 430 | 178 | 13 | GO:0004175 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 3.13e-04 | 144 | 178 | 7 | GO:0016798 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 3.58e-04 | 16 | 178 | 3 | GO:0061809 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 4.40e-04 | 200 | 178 | 8 | GO:0008237 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 1.85e-06 | 44 | 175 | 6 | GO:0006958 | |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 1.38e-05 | 128 | 175 | 8 | GO:0007265 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 1.42e-05 | 62 | 175 | 6 | GO:0002455 | |
| GeneOntologyBiologicalProcess | humoral immune response | REG3G CFI CR2 IGHG2 IGHG3 IGHG4 TREM1 C1R CCR6 DEFB126 YTHDF2 KNG1 | 2.01e-05 | 321 | 175 | 12 | GO:0006959 |
| GeneOntologyBiologicalProcess | complement activation | 2.86e-05 | 70 | 175 | 6 | GO:0006956 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 3.26e-05 | 8 | 175 | 3 | GO:0001812 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 4.86e-05 | 9 | 175 | 3 | GO:0001810 | |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 6.47e-05 | 26 | 175 | 4 | GO:0014061 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 6.90e-05 | 10 | 175 | 3 | GO:0001798 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 6.90e-05 | 10 | 175 | 3 | GO:0016068 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 6.90e-05 | 10 | 175 | 3 | GO:0002894 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 8.74e-05 | 28 | 175 | 4 | GO:0048243 | |
| GeneOntologyBiologicalProcess | negative regulation of Ras protein signal transduction | 8.74e-05 | 28 | 175 | 4 | GO:0046580 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 9.42e-05 | 11 | 175 | 3 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 9.42e-05 | 11 | 175 | 3 | GO:0002892 | |
| GeneOntologyBiologicalProcess | regulation of endocytosis | SYNE1 RAPGEF1 SIGLEC5 ARF6 HPCA EGF RACK1 PROM2 IGHG2 IGHG3 IGHG4 TLR2 | 1.27e-04 | 389 | 175 | 12 | GO:0030100 |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 1.61e-04 | 13 | 175 | 3 | GO:0001788 | |
| GeneOntologyBiologicalProcess | regulation of secretion | CHRNA6 GPR42 IDUA GRM7 PPIA NCS1 ARF6 ADRA2A NF1 OXTR EGF GLP1R CD38 TLR2 HRH2 PLCD1 NOS2 CD200 | 1.65e-04 | 801 | 175 | 18 | GO:0051046 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CHRNA6 SYNE1 NTNG1 GRM7 NCS1 USP8 ADRA2A NF1 OXTR LPA CD38 PLCL2 HRH2 PLG NRG3 ALG13 | 1.74e-04 | 663 | 175 | 16 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CHRNA6 SYNE1 NTNG1 GRM7 NCS1 USP8 ADRA2A NF1 OXTR LPA CD38 PLCL2 HRH2 PLG NRG3 ALG13 | 1.77e-04 | 664 | 175 | 16 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | GPR42 IDUA PPIA ARF6 HPCA YOD1 CCT6A ADRA2A NF1 EGF RACK1 GLP1R CD38 TLR2 NOS2 CD200 | 2.09e-04 | 674 | 175 | 16 | GO:0070201 |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 2.53e-04 | 15 | 175 | 3 | GO:0001794 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 2.53e-04 | 15 | 175 | 3 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 2.53e-04 | 15 | 175 | 3 | GO:0002445 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 2.62e-04 | 67 | 175 | 5 | GO:0050433 | |
| GeneOntologyBiologicalProcess | norepinephrine transport | 2.95e-04 | 38 | 175 | 4 | GO:0015874 | |
| GeneOntologyBiologicalProcess | regulation of protein transport | GPR42 IDUA PPIA ARF6 YOD1 ADRA2A NF1 EGF RACK1 GLP1R CD38 TLR2 NOS2 CD200 | 3.13e-04 | 560 | 175 | 14 | GO:0051223 |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 3.74e-04 | 17 | 175 | 3 | GO:0002866 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 3.90e-04 | 377 | 175 | 11 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 3.99e-04 | 378 | 175 | 11 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 4.08e-04 | 379 | 175 | 11 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 4.09e-04 | 158 | 175 | 7 | GO:0030177 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response | 4.36e-04 | 42 | 175 | 4 | GO:0002675 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 2.10e-04 | 14 | 179 | 3 | GO:0071735 | |
| GeneOntologyCellularComponent | cell surface | MRC1 IDE CR2 GRM7 LDLR SORT1 SULF2 PROM2 IGHG2 IGHG3 IGHG4 LPA CD38 TLR2 SCN5A ADGRE4P TREM1 CCR6 DEFB126 PLG LY75 CD200 | 2.17e-04 | 1111 | 179 | 22 | GO:0009986 |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 3.84e-04 | 17 | 179 | 3 | GO:0042571 | |
| GeneOntologyCellularComponent | ciliary inversin compartment | 4.33e-04 | 4 | 179 | 2 | GO:0097543 | |
| MousePheno | increased susceptibility to induced morbidity/mortality | PEX7 CR2 GRM7 MAP3K1 IFNGR1 HPCAL1 IGHG2 IGHG3 IGHG4 LPA TLR2 SCN5A PLG LY75 NOS2 ALG13 | 4.09e-07 | 346 | 141 | 16 | MP:0009763 |
| MousePheno | decreased IgG2c level | 3.10e-06 | 11 | 141 | 4 | MP:0008897 | |
| MousePheno | absent memory B cells | 3.99e-06 | 4 | 141 | 3 | MP:0008094 | |
| MousePheno | abnormal susceptibility to induced morbidity/mortality | PEX7 CR2 GRM7 MAP3K1 IFNGR1 HPCAL1 IGHG2 IGHG3 IGHG4 LPA TLR2 SCN5A PLD1 PLG LY75 NOS2 ALG13 | 5.25e-06 | 471 | 141 | 17 | MP:0020148 |
| MousePheno | abnormal glial cell physiology | 8.67e-06 | 102 | 141 | 8 | MP:0003690 | |
| MousePheno | abnormal memory B cell morphology | 9.18e-06 | 14 | 141 | 4 | MP:0002440 | |
| MousePheno | abnormal microglial cell physiology | 4.01e-05 | 63 | 141 | 6 | MP:0003691 | |
| MousePheno | abnormal macrophage physiology | MRC1 GALC ERO1A DOCK10 IDUA IL1RL2 YOD1 RASA4 LPA TLR2 RASA4B CCR6 PLG NOS2 CD200 | 5.01e-05 | 451 | 141 | 15 | MP:0002451 |
| MousePheno | abnormal IgG2c level | 5.19e-05 | 21 | 141 | 4 | MP:0020178 | |
| MousePheno | abnormal circulating fibrinogen level | 5.42e-05 | 8 | 141 | 3 | MP:0010213 | |
| MousePheno | decreased memory B cell number | 8.07e-05 | 9 | 141 | 3 | MP:0008729 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 1.01e-04 | 2 | 141 | 2 | MP:0009507 | |
| MousePheno | ectropion | 1.01e-04 | 2 | 141 | 2 | MP:0006164 | |
| MousePheno | esophageal ulcer | 1.01e-04 | 2 | 141 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 1.01e-04 | 2 | 141 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 1.01e-04 | 2 | 141 | 2 | MP:0005035 | |
| MousePheno | decreased susceptibility to induced choroidal neovascularization | 1.14e-04 | 10 | 141 | 3 | MP:0003434 | |
| MousePheno | abnormal innate immunity | MRC1 GALC ERO1A DOCK10 IDUA CFI IL1RL2 IFNGR1 YOD1 RASA4 LPA TLR2 RASA4B CCR6 PLG NOS2 CD96 CD200 | 1.30e-04 | 667 | 141 | 18 | MP:0002419 |
| MousePheno | abnormal choroid vasculature morphology | 1.45e-04 | 27 | 141 | 4 | MP:0006237 | |
| MousePheno | abnormal induced morbidity/mortality | MRC1 PEX7 CR2 GRM7 MAP3K1 IFNGR1 YOD1 HPCAL1 IGHG2 IGHG3 IGHG4 LPA TLR2 SCN5A PLD1 PLG LY75 NOS2 ALG13 | 1.52e-04 | 737 | 141 | 19 | MP:0001657 |
| MousePheno | abnormal memory B cell number | 1.56e-04 | 11 | 141 | 3 | MP:0008093 | |
| MousePheno | abnormal professional antigen presenting cell physiology | MRC1 GALC ERO1A DOCK10 REG3G IDUA CR2 PPIA IL1RL2 IFNGR1 YOD1 RASA4 IGHG2 IGHG3 IGHG4 LPA TLR2 PLCL2 RASA4B CCR6 PLG NOS2 CD200 | 1.71e-04 | 1004 | 141 | 23 | MP:0002452 |
| MousePheno | autoimmune response | DOCK10 CR2 IFNGR1 IGHG2 IGHG3 IGHG4 AVIL CD38 PLCL2 TREM1 CCR6 NOS2 CD200 | 1.94e-04 | 398 | 141 | 13 | MP:0001844 |
| MousePheno | abnormal self tolerance | DOCK10 CR2 IFNGR1 IGHG2 IGHG3 IGHG4 AVIL CD38 PLCL2 TREM1 CCR6 NOS2 CD200 | 2.04e-04 | 400 | 141 | 13 | MP:0005005 |
| MousePheno | abnormal immune tolerance | DOCK10 CR2 IFNGR1 IGHG2 IGHG3 IGHG4 AVIL CD38 PLCL2 TREM1 CCR6 NOS2 CD200 | 2.25e-04 | 404 | 141 | 13 | MP:0005000 |
| MousePheno | absent cornea epithelium | 3.01e-04 | 3 | 141 | 2 | MP:0020856 | |
| MousePheno | abnormal physiological response to xenobiotic | GPR42 USP24 NMRAL1 GRM7 IL1RL2 IFNGR1 HPCA SLC12A3 HPCAL1 IGHG2 IGHG3 IGHG4 LPA TREM1 PLG CD96 ALG13 | 3.62e-04 | 662 | 141 | 17 | MP:0008872 |
| MousePheno | abnormal leukocyte physiology | MRC1 GALC ERO1A DOCK10 REG3G SIGLEC5 IDUA CR2 PPIA IL1RL2 IFNGR1 YOD1 NF1 RASA4 IGHG2 IGHG3 IGHG4 LPA CD38 TLR2 PLCL2 RASA4B CCR6 PLG LY75 NOS2 CD96 CD200 | 4.12e-04 | 1425 | 141 | 28 | MP:0002442 |
| MousePheno | abnormal plasma cell differentiation | 4.18e-04 | 15 | 141 | 3 | MP:0008099 | |
| MousePheno | abnormal CNS glial cell morphology | 4.35e-04 | 272 | 141 | 10 | MP:0000952 | |
| MousePheno | abnormal granulocyte number | MRC1 CHIA SIGLEC5 SLC7A7 CR2 IL1RL2 YOD1 KLK4 SCARB2 ADAMTS16 TREM1 PTCH2 ZNF721 PLCD1 CCDC183 ZNF99 NOS2 MFSD1 HDC | 4.62e-04 | 805 | 141 | 19 | MP:0020201 |
| MousePheno | increased inflammatory response | GALC SYNE1 PEX7 SIGLEC5 CPA1 IDUA PPIA LDLR MAP3K1 IFNGR1 YOD1 NPHP3 IGHG2 IGHG3 IGHG4 LPA NEK8 CD38 TLR2 PLG NOS2 CD96 CD200 | 4.68e-04 | 1077 | 141 | 23 | MP:0001846 |
| MousePheno | abnormal myeloid leukocyte morphology | MRC1 GALC CHIA PEX7 SIGLEC5 SLC7A7 IDUA CR2 IL1RL2 LDLR IFNGR1 YOD1 KLK4 SCARB2 ADAMTS16 TREM1 PTCH2 ZNF721 CCR6 PLCD1 CCDC183 ZNF99 NOS2 MFSD1 CD200 HDC | 4.79e-04 | 1292 | 141 | 26 | MP:0008250 |
| MousePheno | decreased cell migration | 4.94e-04 | 65 | 141 | 5 | MP:0011805 | |
| MousePheno | abnormal immune cell physiology | MRC1 GALC ERO1A DOCK10 REG3G SIGLEC5 IDUA CR2 PPIA IL1RL2 IFNGR1 YOD1 NF1 RASA4 IGHG2 IGHG3 IGHG4 LPA CD38 TLR2 PLCL2 RASA4B CCR6 PLG LY75 NOS2 CD96 CD200 | 5.45e-04 | 1450 | 141 | 28 | MP:0001819 |
| MousePheno | increased circulating fibrinogen level | 5.98e-04 | 4 | 141 | 2 | MP:0012331 | |
| MousePheno | increased susceptibility to experimental autoimmune uveoretinitis | 5.98e-04 | 4 | 141 | 2 | MP:0004821 | |
| MousePheno | proctitis | 5.98e-04 | 4 | 141 | 2 | MP:0003305 | |
| MousePheno | increased hepatocyte proliferation | 6.16e-04 | 17 | 141 | 3 | MP:0003893 | |
| MousePheno | lactation failure | 6.16e-04 | 17 | 141 | 3 | MP:0010249 | |
| MousePheno | enhanced humoral immune response | 6.16e-04 | 17 | 141 | 3 | MP:0020155 | |
| MousePheno | abnormal cell-mediated immunity | MRC1 GALC ERO1A DOCK10 REG3G SIGLEC5 IDUA CR2 PPIA IL1RL2 IFNGR1 YOD1 NF1 RASA4 IGHG2 IGHG3 IGHG4 LPA CD38 TLR2 PLCL2 RASA4B CCR6 PLG LY75 NOS2 CD96 CD200 | 6.28e-04 | 1463 | 141 | 28 | MP:0002421 |
| MousePheno | abnormal granulocyte morphology | MRC1 CHIA SIGLEC5 SLC7A7 CR2 IL1RL2 YOD1 KLK4 SCARB2 ADAMTS16 TREM1 PTCH2 ZNF721 PLCD1 CCDC183 ZNF99 NOS2 MFSD1 HDC | 7.21e-04 | 835 | 141 | 19 | MP:0002441 |
| MousePheno | abnormal glial cell morphology | GALC IDUA LDLR ADAM22 MAP3K1 SCARB2 TLR2 AFG3L2 NOS2 CD200 ALG13 | 7.45e-04 | 345 | 141 | 11 | MP:0003634 |
| MousePheno | abnormal lactation | 7.91e-04 | 72 | 141 | 5 | MP:0001882 | |
| MousePheno | pancreas inflammation | 7.91e-04 | 72 | 141 | 5 | MP:0001869 | |
| MousePheno | abnormal adaptive immunity | MRC1 GALC ERO1A DOCK10 REG3G SIGLEC5 IDUA CR2 PPIA IL1RL2 IFNGR1 YOD1 NF1 RASA4 IGHG2 IGHG3 IGHG4 LPA CD38 TLR2 PLCL2 RASA4B CCR6 PLG LY75 NOS2 CD96 CD200 | 8.37e-04 | 1490 | 141 | 28 | MP:0002420 |
| MousePheno | choroidal neovascularization | 8.65e-04 | 19 | 141 | 3 | MP:0005546 | |
| Domain | YIPPEE | 8.11e-06 | 5 | 176 | 3 | PS51792 | |
| Domain | Yippee/Mis18/Cereblon | 4.45e-05 | 8 | 176 | 3 | IPR004910 | |
| Domain | Yippee-Mis18 | 4.45e-05 | 8 | 176 | 3 | PF03226 | |
| Domain | Chap_CCT_zeta | 8.83e-05 | 2 | 176 | 2 | IPR012722 | |
| Domain | Recoverin | 2.19e-04 | 13 | 176 | 3 | IPR028846 | |
| Domain | Kringle-like | 2.23e-04 | 32 | 176 | 4 | IPR013806 | |
| Domain | - | 2.63e-04 | 3 | 176 | 2 | 4.10.1130.10 | |
| Domain | RasGAP | 2.77e-04 | 14 | 176 | 3 | SM00323 | |
| Domain | Myotubularin-like_Pase_dom | 2.77e-04 | 14 | 176 | 3 | IPR010569 | |
| Domain | PPASE_MYOTUBULARIN | 2.77e-04 | 14 | 176 | 3 | PS51339 | |
| Domain | Myotubularin_fam | 2.77e-04 | 14 | 176 | 3 | IPR030564 | |
| Domain | Myotub-related | 2.77e-04 | 14 | 176 | 3 | PF06602 | |
| Domain | RasGAP_CS | 2.77e-04 | 14 | 176 | 3 | IPR023152 | |
| Domain | RasGAP | 3.44e-04 | 15 | 176 | 3 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 3.44e-04 | 15 | 176 | 3 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 3.44e-04 | 15 | 176 | 3 | PS50018 | |
| Domain | EGF | 3.99e-04 | 235 | 176 | 9 | SM00181 | |
| Domain | EGF_3 | 3.99e-04 | 235 | 176 | 9 | PS50026 | |
| Domain | - | 5.23e-04 | 4 | 176 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 5.23e-04 | 4 | 176 | 2 | PS51139 | |
| Domain | GTF2I | 5.23e-04 | 4 | 176 | 2 | PF02946 | |
| Domain | GTF2I | 5.23e-04 | 4 | 176 | 2 | IPR004212 | |
| Domain | RasGAP_dom | 6.05e-04 | 18 | 176 | 3 | IPR001936 | |
| Domain | EGF-like_dom | 6.06e-04 | 249 | 176 | 9 | IPR000742 | |
| Domain | Cyclophilin-type_PPIase_CS | 7.13e-04 | 19 | 176 | 3 | IPR020892 | |
| Domain | EGF_1 | 7.19e-04 | 255 | 176 | 9 | PS00022 | |
| Domain | PH_dom-like | RALGPS2 DOCK10 MTMR1 EPS8L1 MTMR10 RASA4 PLCL2 MTMR3 RASA4B PLCD1 PLD1 DCP1A | 7.39e-04 | 426 | 176 | 12 | IPR011993 |
| Domain | EGF-like_CS | 8.47e-04 | 261 | 176 | 9 | IPR013032 | |
| Domain | EGF_2 | 9.43e-04 | 265 | 176 | 9 | PS01186 | |
| Domain | C_TYPE_LECTIN_1 | 9.54e-04 | 80 | 176 | 5 | PS00615 | |
| Domain | Cyclophilin-type_PPIase | 9.66e-04 | 21 | 176 | 3 | IPR024936 | |
| Domain | Pro_isomerase | 1.11e-03 | 22 | 176 | 3 | PF00160 | |
| Domain | Cyclophilin-type_PPIase_dom | 1.11e-03 | 22 | 176 | 3 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 1.11e-03 | 22 | 176 | 3 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 1.11e-03 | 22 | 176 | 3 | PS50072 | |
| Domain | - | 1.11e-03 | 22 | 176 | 3 | 2.40.100.10 | |
| Domain | CSA_PPIASE_1 | 1.11e-03 | 22 | 176 | 3 | PS00170 | |
| Domain | Lectin_C | 1.19e-03 | 84 | 176 | 5 | PF00059 | |
| Domain | CLECT | 1.19e-03 | 84 | 176 | 5 | SM00034 | |
| Domain | - | RALGPS2 DOCK10 MTMR1 MTMR10 RASA4 PLCL2 MTMR3 RASA4B PLCD1 PLD1 DCP1A | 1.24e-03 | 391 | 176 | 11 | 2.30.29.30 |
| Domain | C_TYPE_LECTIN_2 | 1.25e-03 | 85 | 176 | 5 | PS50041 | |
| Domain | C-type_lectin-like | 1.32e-03 | 86 | 176 | 5 | IPR001304 | |
| Domain | - | 1.62e-03 | 25 | 176 | 3 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 1.62e-03 | 25 | 176 | 3 | IPR017946 | |
| Pubmed | 2.45e-08 | 7 | 181 | 4 | 18322226 | ||
| Pubmed | 2.45e-08 | 7 | 181 | 4 | 25505290 | ||
| Pubmed | The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. | 8.76e-08 | 9 | 181 | 4 | 8041705 | |
| Pubmed | Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice. | 1.39e-07 | 3 | 181 | 3 | 21311769 | |
| Pubmed | 1.39e-07 | 3 | 181 | 3 | 33827130 | ||
| Pubmed | BTG1 mutation yields supercompetitive B cells primed for malignant transformation. | 2.28e-07 | 11 | 181 | 4 | 36656933 | |
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 5.52e-07 | 4 | 181 | 3 | 11812141 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6794027 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 5.52e-07 | 4 | 181 | 3 | 2510996 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 5.52e-07 | 4 | 181 | 3 | 19050247 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 7892607 | ||
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 5.52e-07 | 4 | 181 | 3 | 8438159 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 4098598 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6253932 | ||
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 5.52e-07 | 4 | 181 | 3 | 6769752 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 1542303 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 9725203 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 4831970 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 12209645 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 116231 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 5.52e-07 | 4 | 181 | 3 | 6283537 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6777755 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6297797 | ||
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 5.52e-07 | 4 | 181 | 3 | 98524 | |
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 5.52e-07 | 4 | 181 | 3 | 6799207 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6787604 | ||
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 5.52e-07 | 4 | 181 | 3 | 6767246 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 12051834 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 8683112 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6804950 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 5.52e-07 | 4 | 181 | 3 | 19592272 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 10720538 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 15699144 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 2513486 | ||
| Pubmed | Independent immunoglobulin class-switch events occurring in a single myeloma cell line. | 5.52e-07 | 4 | 181 | 3 | 3921826 | |
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 5.52e-07 | 4 | 181 | 3 | 113776 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 5.52e-07 | 4 | 181 | 3 | 1754385 | |
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 5.52e-07 | 4 | 181 | 3 | 30287618 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 4565406 | ||
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 5.52e-07 | 4 | 181 | 3 | 25363774 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 20621099 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 5.52e-07 | 4 | 181 | 3 | 12414967 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 5.52e-07 | 4 | 181 | 3 | 6803173 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6264445 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 5.52e-07 | 4 | 181 | 3 | 25867470 | |
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 5.52e-07 | 4 | 181 | 3 | 9126488 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 8452816 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 7439686 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6278424 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 35133976 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 8099342 | ||
| Pubmed | Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation. | 5.52e-07 | 4 | 181 | 3 | 32006024 | |
| Pubmed | Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. | 5.52e-07 | 4 | 181 | 3 | 117549 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 25451975 | ||
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 5.52e-07 | 4 | 181 | 3 | 6801765 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6306571 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 1672339 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 5.52e-07 | 4 | 181 | 3 | 1713710 | |
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 5.52e-07 | 4 | 181 | 3 | 9103199 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 38268239 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6170065 | ||
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 5.52e-07 | 4 | 181 | 3 | 19703988 | |
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 5.52e-07 | 4 | 181 | 3 | 807855 | |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 4166666 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 26201558 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6249338 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 24752300 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 36763580 | ||
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 6262729 | ||
| Pubmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. | 5.52e-07 | 4 | 181 | 3 | 26683050 | |
| Pubmed | Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. | 5.52e-07 | 4 | 181 | 3 | 6766534 | |
| Pubmed | 5.62e-07 | 300 | 181 | 11 | 19086053 | ||
| Pubmed | Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. | 6.55e-07 | 59 | 181 | 6 | 17330941 | |
| Pubmed | Dynamic regulation of B cell complement signaling is integral to germinal center responses. | 1.23e-06 | 16 | 181 | 4 | 34031614 | |
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 1.38e-06 | 5 | 181 | 3 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 1.38e-06 | 5 | 181 | 3 | 6770027 | |
| Pubmed | Tankyrase represses autoinflammation through the attenuation of TLR2 signaling. | 1.38e-06 | 5 | 181 | 3 | 35362478 | |
| Pubmed | A novel allele for inducible Cre expression in germinal center BÂ cells. | 1.38e-06 | 5 | 181 | 3 | 30359469 | |
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 23423996 | ||
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 32229726 | ||
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 33025844 | ||
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 27167731 | ||
| Pubmed | Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). | 1.38e-06 | 5 | 181 | 3 | 9743367 | |
| Pubmed | Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. | 1.38e-06 | 5 | 181 | 3 | 7704573 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 1.38e-06 | 5 | 181 | 3 | 20031218 | |
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 9834201 | ||
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 103631 | ||
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 33163250 | ||
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 37310381 | ||
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 36853944 | ||
| Pubmed | The disulphide bridges of a mouse immunoglobulin G1 protein. | 1.38e-06 | 5 | 181 | 3 | 5073237 | |
| Pubmed | Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. | 1.38e-06 | 5 | 181 | 3 | 35044826 | |
| Pubmed | Sequential class switching is required for the generation of high affinity IgE antibodies. | 1.38e-06 | 5 | 181 | 3 | 22249450 | |
| Pubmed | The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program. | 1.38e-06 | 5 | 181 | 3 | 26620759 | |
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 32640012 | ||
| Pubmed | Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation. | 1.38e-06 | 5 | 181 | 3 | 34539636 | |
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 3031474 | ||
| Pubmed | 1.38e-06 | 5 | 181 | 3 | 36779803 | ||
| Pubmed | Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. | 1.38e-06 | 5 | 181 | 3 | 6798155 | |
| Cytoband | 10q22-q23 | 1.53e-04 | 5 | 181 | 2 | 10q22-q23 | |
| GeneFamily | Yippee like family | 3.35e-06 | 5 | 127 | 3 | 1130 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | MRC1 SIGLEC5 CR2 IFNGR1 CD38 TLR2 TREM1 CCR6 LY75 CD96 CD200 | 1.06e-04 | 394 | 127 | 11 | 471 |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 1.45e-04 | 15 | 127 | 3 | 903 | |
| GeneFamily | OTU domain containing | 2.14e-04 | 17 | 127 | 3 | 669 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 8.75e-04 | 27 | 127 | 3 | 1253 | |
| GeneFamily | Complement system|Sushi domain containing | 2.04e-03 | 36 | 127 | 3 | 492 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 2.12e-03 | 10 | 127 | 2 | 830 | |
| GeneFamily | Helix-turn-helix CENPB type domain containing | 3.63e-03 | 13 | 127 | 2 | 533 | |
| Coexpression | GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN | 1.02e-05 | 200 | 179 | 9 | M8196 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN | 1.02e-05 | 200 | 179 | 9 | M6247 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP | 1.02e-05 | 200 | 179 | 9 | M7648 | |
| ToppCell | Control-B_intermediate-14|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | TDRD15 RALGPS2 DOCK10 PPIA PHKB PTPN12 RACK1 IGHG2 IGHG3 IGHG4 | 6.47e-09 | 191 | 181 | 10 | 076302fd247aab6c0b187ac9e0c67a3ba46414ba |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | DPYD DOCK10 SPECC1 MAP3K1 IFNGR1 SULF2 TLR2 PLCL2 HRH2 OTULINL | 7.14e-09 | 193 | 181 | 10 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOpos|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.16e-07 | 196 | 181 | 9 | a4c9f46ff75dbdd43ad369ceda604fb1650d8a9a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.32e-07 | 199 | 181 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.32e-07 | 199 | 181 | 9 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.32e-07 | 199 | 181 | 9 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.37e-07 | 200 | 181 | 9 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-07 | 151 | 181 | 8 | c743dc8758416a4f562d60c8fd2df7e659ab6951 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-07 | 157 | 181 | 8 | 63502d0fd5972d71cdbe13bde167592c70acec32 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.59e-07 | 163 | 181 | 8 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.59e-07 | 163 | 181 | 8 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | IPF-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 6.42e-07 | 176 | 181 | 8 | cc0cab6487df6867b529596ec94f55d31aa6ca36 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-07 | 179 | 181 | 8 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 8.27e-07 | 182 | 181 | 8 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.98e-07 | 184 | 181 | 8 | 8e5fc2bdd3071e782aa8c56b8a39f8ea8f03f623 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-07 | 184 | 181 | 8 | f81209e6bc01a0140f4487aa8b22eb02fbf0c39c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.36e-07 | 185 | 181 | 8 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 189 | 181 | 8 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 190 | 181 | 8 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-06 | 196 | 181 | 8 | fc67d8aad1ec4d7f98ffe44fb103e230b9b42c35 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-06 | 196 | 181 | 8 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | 356C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-06 | 197 | 181 | 8 | 896242e1651435bbc5b6521417e1aca36c215acd | |
| ToppCell | BAL-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 1.62e-06 | 199 | 181 | 8 | d39be8b173156bf87baddd3caed4b35597c53ea1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-06 | 150 | 181 | 7 | 17da17f01a3d41ac7df20f806e3eae30eca06982 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-06 | 150 | 181 | 7 | 8702d5bb419d5e997d388e8f7e0365ba5d1de8d5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-06 | 150 | 181 | 7 | 8b781ec3e6c2adf052d46d724e2aef72b0c27d13 | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 3.00e-06 | 152 | 181 | 7 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 3.57e-06 | 156 | 181 | 7 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | normal_Lung-B_lymphocytes-Undetermined|normal_Lung / Location, Cell class and cell subclass | 4.05e-06 | 159 | 181 | 7 | f89fc18966d9b9b33e81e7b9eb3ec3420c20ff43 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.22e-06 | 160 | 181 | 7 | 694bf1f1952bd8ab444819f533da24fa2b73f701 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.58e-06 | 162 | 181 | 7 | 7c73fe8388af370461e04097cf145cbc9847285b | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 5.81e-06 | 168 | 181 | 7 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | Control-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 6.28e-06 | 170 | 181 | 7 | fb05f49b7113470995b3c16683c54dc1a660b73a | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 170 | 181 | 7 | 670027daec5a10dfa12246f1497b58db21d32a22 | |
| ToppCell | Control-Lymphoid-B_Plasma|Control / Disease state, Lineage and Cell class | 6.78e-06 | 172 | 181 | 7 | 61e33836b8cb0f347f3e699eb587a37073b6fa4c | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.78e-06 | 172 | 181 | 7 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.05e-06 | 173 | 181 | 7 | fde1fabb8d13d05998ac3f21ecb1fde6a7a2f337 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.05e-06 | 173 | 181 | 7 | dcde3252ff96448d3a61039a4948c74ad321a218 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|normal_Lung / Location, Cell class and cell subclass | 7.88e-06 | 176 | 181 | 7 | f31d7234053085a82cf9d55aeedd1e04d34789c3 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.88e-06 | 176 | 181 | 7 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | IPF-Lymphoid-B_Plasma|IPF / Disease state, Lineage and Cell class | 7.88e-06 | 176 | 181 | 7 | e4f33f6cd140dd4fa3002bcd65ac8005d27865d1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-06 | 177 | 181 | 7 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | -IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 8.18e-06 | 177 | 181 | 7 | ae2d2e138946535596fa30a55207f261cafda461 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.18e-06 | 177 | 181 | 7 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.49e-06 | 178 | 181 | 7 | f914092c20130207193f97c6044ae61a9a440a86 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.49e-06 | 178 | 181 | 7 | 7905621f5b2aa55324c5592d1d2fef763a5fa41f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-06 | 179 | 181 | 7 | 6eb84fe9691ad40127b2d1f1c672428333c8fab4 | |
| ToppCell | normal_Lung-B_lymphocytes|normal_Lung / Location, Cell class and cell subclass | 8.80e-06 | 179 | 181 | 7 | 5b89193486100b6754c1c5eca3105ea955805eae | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.80e-06 | 179 | 181 | 7 | 31411780f1a44bf2d102f288416e97eacec4b6b6 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-06 | 179 | 181 | 7 | 2c3abd646d2c8992e8ff76a824eab5beba8ba4c6 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.46e-06 | 181 | 181 | 7 | 092a971661b0aa06c1cdf428dbfa7339a26fb678 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 181 | 181 | 7 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.81e-06 | 182 | 181 | 7 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-06 | 182 | 181 | 7 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 183 | 181 | 7 | 59e8d07556390828f7557ba3fd2f7d49851498b7 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 183 | 181 | 7 | 2c5707ada3442eb7100a2a5f9438d5a2ac53a9e1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 183 | 181 | 7 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 184 | 181 | 7 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 184 | 181 | 7 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22-_mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 184 | 181 | 7 | 18aa9c43b79d12c9e420dfd9822745c022be6789 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-05 | 184 | 181 | 7 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-05 | 184 | 181 | 7 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | 3261d767d5e3d9e9fbac22ad73ca14e44beed89c | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 185 | 181 | 7 | eb338fcda0b237c2e0b9b4b0daf51febbfe1d79c | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 185 | 181 | 7 | c31bb53852caf36964b83b28bcaee07b679da779 | |
| ToppCell | Control-Lymphocyte-B|Control / Disease, Lineage and Cell Type | 1.09e-05 | 185 | 181 | 7 | cb61b5ff6a2ef71c94469c35cafc21df5bcf61b1 | |
| ToppCell | -IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.09e-05 | 185 | 181 | 7 | 10f7e5daf8e95dda9453212e84b64874f4e0d7ab | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 186 | 181 | 7 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 186 | 181 | 7 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 1.13e-05 | 186 | 181 | 7 | a08a50bff4e629588faa22440d57334b1df0e8df | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 186 | 181 | 7 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 181 | 7 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | Immune-B_cell|World / Lineage, Cell type, age group and donor | 1.17e-05 | 187 | 181 | 7 | 795690c6306c366e733279491138d0cd9b469b21 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 181 | 7 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 187 | 181 | 7 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 188 | 181 | 7 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 188 | 181 | 7 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-05 | 189 | 181 | 7 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 189 | 181 | 7 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 189 | 181 | 7 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 190 | 181 | 7 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 190 | 181 | 7 | 92456f6f7eced6e4c4371f495254a65d061c8d0b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.43e-05 | 193 | 181 | 7 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | background-NK_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.43e-05 | 193 | 181 | 7 | f8d6eff1e04926f85d265ec39fe66897fe29574d | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.43e-05 | 193 | 181 | 7 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.43e-05 | 193 | 181 | 7 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.48e-05 | 194 | 181 | 7 | 885355ebe98e974f841cc59dce3b5228c642c5d0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-05 | 194 | 181 | 7 | 421344cc4b601d9745fa72d0af3124dab11d1d27 | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.53e-05 | 195 | 181 | 7 | c5ed36f649dc43c2811637890bbc5192981c7311 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-05 | 195 | 181 | 7 | bb30ac112f8c42d113fa83a9b662e40c0685bb1e | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Plasma_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.64e-05 | 197 | 181 | 7 | 7ffb373d5b72c67e4816f14ea9a7a2024dc7a93a | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.64e-05 | 197 | 181 | 7 | 2e76e9ebd8702bfeefd396cbf5114eee0f24c19b | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-05 | 197 | 181 | 7 | 0d38d126b1e653398426255e95449f1150eac1b0 | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.64e-05 | 197 | 181 | 7 | 207fce47e547fafbaf64a22efe3488e74bf19bed | |
| ToppCell | Biopsy_Control_(H.)-Immune-Plasma_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.64e-05 | 197 | 181 | 7 | 275f38ed7e477000e864cecf9b7d49ae134c3b6a | |
| ToppCell | 343B-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 197 | 181 | 7 | 1b6f7a62b7fcfd55c25c5840353eed7183050860 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-05 | 198 | 181 | 7 | 4aa4ae2571effcfb6eb6923f7173cd3e7e4af9ef | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.69e-05 | 198 | 181 | 7 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.75e-05 | 199 | 181 | 7 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-B|ICU-SEP / Disease, condition lineage and cell class | 1.75e-05 | 199 | 181 | 7 | 5d4800d0a6340a9db4e895375cf55eeae464709e | |
| Drug | vasopressin | CPA6 KLK4 ADRA2A NPHP3 OXTR EGF SLC12A3 PIK3C2G LPA BEST4 CD38 PLCD1 PLD1 NOS2 KNG1 | 4.04e-07 | 388 | 177 | 15 | CID011979316 |
| Drug | mangrove | CHRNA6 GALC PNLIPRP1 LALBA PEX7 LDLR CHRND EGF PIK3C2G RASA4 LPA SCARB2 ACOT2 PLD1 PLG NOS2 | 8.39e-07 | 468 | 177 | 16 | CID000000965 |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 3.44e-06 | 197 | 177 | 10 | 1528_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; PC3; HT_HG-U133A | SYNE1 RALGPS2 NTNG1 ATP10B EPS8L1 NEB SORT1 NF1 PLCD1 OTULINL | 3.44e-06 | 197 | 177 | 10 | 4077_UP |
| Drug | AC1N9TEG | 5.82e-06 | 124 | 177 | 8 | CID000000478 | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.29e-05 | 195 | 177 | 9 | 3553_UP | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; PC3; HT_HG-U133A | 2.29e-05 | 195 | 177 | 9 | 3789_UP | |
| Drug | Benzamil hydrochloride [2898-76-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.38e-05 | 196 | 177 | 9 | 4294_UP | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 5592_UP | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 3532_UP | |
| Drug | kinin 9 | CPA6 CPA1 SORT1 KLK4 EGF RASA4 CD38 PLCD1 PLD1 PLG NOS2 KNG1 | 2.88e-05 | 363 | 177 | 12 | CID000006026 |
| Drug | prostaglandin F2 | 2.92e-05 | 306 | 177 | 11 | CID000000160 | |
| Disease | renal-hepatic-pancreatic dysplasia (is_implicated_in) | 3.42e-05 | 2 | 173 | 2 | DOID:0060259 (is_implicated_in) | |
| Disease | RENAL-HEPATIC-PANCREATIC DYSPLASIA | 3.42e-05 | 2 | 173 | 2 | C2673883 | |
| Disease | immunoglobulin G measurement | 3.42e-05 | 2 | 173 | 2 | EFO_0020465 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 4.61e-05 | 34 | 173 | 4 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | response to statin, LDL cholesterol change measurement | 8.56e-05 | 15 | 173 | 3 | EFO_0007804, GO_0036273 | |
| Disease | Hypertensive disease | 1.36e-04 | 190 | 173 | 7 | C0020538 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.54e-04 | 46 | 173 | 4 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | Liver Cirrhosis, Experimental | YPEL3 GALC DOCK10 SIGLEC5 IFNGR1 TSC22D1 EGF HPCAL1 UNC5CL CD38 OTULINL PLG NOS2 KNG1 | 2.01e-04 | 774 | 173 | 14 | C0023893 |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.02e-04 | 91 | 173 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | bacterial pneumonia (implicated_via_orthology) | 2.03e-04 | 4 | 173 | 2 | DOID:874 (implicated_via_orthology) | |
| Disease | Macrostomia | 2.03e-04 | 4 | 173 | 2 | C0024433 | |
| Disease | total phospholipids in lipoprotein particles measurement | 2.67e-04 | 53 | 173 | 4 | EFO_0022315 | |
| Disease | diet measurement, fasting blood insulin measurement | 2.81e-04 | 22 | 173 | 3 | EFO_0004466, EFO_0008111 | |
| Disease | Antithrombotic agent use measurement | 3.08e-04 | 55 | 173 | 4 | EFO_0009925 | |
| Disease | diet measurement, HOMA-IR | 3.22e-04 | 23 | 173 | 3 | EFO_0004501, EFO_0008111 | |
| Disease | triglycerides in LDL measurement | 3.30e-04 | 56 | 173 | 4 | EFO_0022320 | |
| Disease | cholesterol to total lipids in large LDL percentage | 3.30e-04 | 56 | 173 | 4 | EFO_0022235 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 3.30e-04 | 56 | 173 | 4 | EFO_0022279 | |
| Disease | plasma plasminogen measurement | 3.38e-04 | 5 | 173 | 2 | EFO_0006309 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 3.38e-04 | 5 | 173 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | acute pancreatitis (implicated_via_orthology) | 3.38e-04 | 5 | 173 | 2 | DOID:2913 (implicated_via_orthology) | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.71e-04 | 224 | 173 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | low density lipoprotein particle size measurement | 3.78e-04 | 58 | 173 | 4 | EFO_0008593 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 4.24e-04 | 229 | 173 | 7 | EFO_0004639, EFO_0008317 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 4.56e-04 | 166 | 173 | 6 | EFO_0004530, EFO_0004611 | |
| Disease | free cholesterol in IDL measurement | 4.59e-04 | 61 | 173 | 4 | EFO_0022181 | |
| Disease | triglycerides in medium LDL measurement | 4.88e-04 | 62 | 173 | 4 | EFO_0022322 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 5.05e-04 | 6 | 173 | 2 | C1854678 | |
| Disease | complement C1q subcomponent measurement | 5.05e-04 | 6 | 173 | 2 | EFO_0008089 | |
| Disease | angiostatin measurement | 5.05e-04 | 6 | 173 | 2 | EFO_0008024 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 5.19e-04 | 63 | 173 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 5.19e-04 | 63 | 173 | 4 | EFO_0022239 | |
| Disease | lipoprotein A measurement | 5.29e-04 | 112 | 173 | 5 | EFO_0006925 | |
| Disease | Bipolar Disorder | 5.41e-04 | 477 | 173 | 10 | C0005586 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 5.51e-04 | 64 | 173 | 4 | EFO_0022253 | |
| Disease | Malignant neoplasm of breast | KDM3A DPYD PNLIPRP1 SYNE1 UBR4 DNAJC21 SLC7A7 MAP3K1 CHRND PHKB SULF2 NF1 EGF MTMR3 TREM1 NOS2 | 6.13e-04 | 1074 | 173 | 16 | C0006142 |
| Disease | free cholesterol in large VLDL measurement | 6.94e-04 | 68 | 173 | 4 | EFO_0022265 | |
| Disease | hereditary angioedema (is_implicated_in) | 7.04e-04 | 7 | 173 | 2 | DOID:14735 (is_implicated_in) | |
| Disease | contrast sensitivity measurement | 7.04e-04 | 7 | 173 | 2 | EFO_0005419 | |
| Disease | gallbladder cancer (is_marker_for) | 7.04e-04 | 7 | 173 | 2 | DOID:3121 (is_marker_for) | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 7.04e-04 | 7 | 173 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | Schizophrenia | DPYD NTNG1 IDE GRM7 PPIA NCS1 ADRA2A OXTR TLR2 PLCL2 TREM1 SNX31 PLG NRG3 | 7.44e-04 | 883 | 173 | 14 | C0036341 |
| Disease | NEPHRONOPHTHISIS 2 | 9.35e-04 | 8 | 173 | 2 | C1865872 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.06e-03 | 195 | 173 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Nephronophthisis | 1.20e-03 | 9 | 173 | 2 | cv:C0687120 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 1.20e-03 | 9 | 173 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | Oxidative Phosphorylation Deficiencies | 1.20e-03 | 9 | 173 | 2 | C0949856 | |
| Disease | Mitochondrial Respiratory Chain Deficiencies | 1.20e-03 | 9 | 173 | 2 | C0949857 | |
| Disease | Electron Transport Chain Deficiencies, Mitochondrial | 1.20e-03 | 9 | 173 | 2 | C0949855 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.31e-03 | 137 | 173 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.33e-03 | 37 | 173 | 3 | EFO_0022281 | |
| Disease | MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) | 1.49e-03 | 10 | 173 | 2 | C1834752 | |
| Disease | Mycobacterium tuberculosis, susceptibility to | 1.49e-03 | 10 | 173 | 2 | cv:C1834752 | |
| Disease | MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO | 1.49e-03 | 10 | 173 | 2 | 607948 | |
| Disease | Otitis media | 1.55e-03 | 39 | 173 | 3 | EFO_0004992 | |
| Disease | aspirin use measurement | 1.55e-03 | 39 | 173 | 3 | EFO_0007013 | |
| Disease | Hypercholesterolemia | 1.55e-03 | 39 | 173 | 3 | C0020443 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 1.67e-03 | 40 | 173 | 3 | EFO_0004746 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.71e-03 | 291 | 173 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | Kidney Diseases | 1.81e-03 | 88 | 173 | 4 | C0022658 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.95e-03 | 220 | 173 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.95e-03 | 150 | 173 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 2.06e-03 | 43 | 173 | 3 | EFO_0022290 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.13e-03 | 224 | 173 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | psoriasis (is_marker_for) | 2.20e-03 | 44 | 173 | 3 | DOID:8893 (is_marker_for) | |
| Disease | cholesterol to total lipids in large VLDL percentage | 2.35e-03 | 45 | 173 | 3 | EFO_0022236 | |
| Disease | Alzheimer disease | 2.35e-03 | 485 | 173 | 9 | MONDO_0004975 | |
| Disease | asthma (is_implicated_in) | 2.38e-03 | 157 | 173 | 5 | DOID:2841 (is_implicated_in) | |
| Disease | lung disease (implicated_via_orthology) | 2.55e-03 | 13 | 173 | 2 | DOID:850 (implicated_via_orthology) | |
| Disease | Reactive Hyperemia | 2.55e-03 | 13 | 173 | 2 | C0178824 | |
| Disease | Venous Engorgement | 2.55e-03 | 13 | 173 | 2 | C0042484 | |
| Disease | Nephronophthisis | 2.55e-03 | 13 | 173 | 2 | C0687120 | |
| Disease | Active Hyperemia | 2.55e-03 | 13 | 173 | 2 | C0333233 | |
| Disease | Hyperemia | 2.55e-03 | 13 | 173 | 2 | C0020452 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 2.79e-03 | 99 | 173 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | breast carcinoma | GALC YPEL2 GRM7 MAP3K1 GTF2IRD2B SLC12A3 STAG3L1 LPA PLCL2 ADAMTS16 MTMR3 GTF2IRD2 PLG NRG3 | 2.82e-03 | 1019 | 173 | 14 | EFO_0000305 |
| Disease | total lipids in lipoprotein particles measurement | 2.82e-03 | 48 | 173 | 3 | EFO_0022309 | |
| Disease | phosphoglycerides measurement | 2.82e-03 | 48 | 173 | 3 | EFO_0022291 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.97e-03 | 14 | 173 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 2.99e-03 | 49 | 173 | 3 | EFO_0022256 | |
| Disease | Acute kidney injury | 3.00e-03 | 101 | 173 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 3.00e-03 | 101 | 173 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 3.00e-03 | 101 | 173 | 4 | C0022660 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.19e-03 | 243 | 173 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 3.33e-03 | 104 | 173 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 3.36e-03 | 51 | 173 | 3 | EFO_0022242 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 3.36e-03 | 51 | 173 | 3 | EFO_0022285 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.44e-03 | 171 | 173 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 3.69e-03 | 107 | 173 | 4 | EFO_0004614, EFO_0004615 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 3.74e-03 | 53 | 173 | 3 | EFO_0022340 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 3.74e-03 | 53 | 173 | 3 | EFO_0022258 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 3.89e-03 | 16 | 173 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.89e-03 | 16 | 173 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | total lipids in medium VLDL | 3.95e-03 | 54 | 173 | 3 | EFO_0022153 | |
| Disease | plasminogen activator inhibitor 1 measurement | 3.95e-03 | 54 | 173 | 3 | EFO_0004792 | |
| Disease | Hepatomegaly | 3.95e-03 | 54 | 173 | 3 | C0019209 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 3.95e-03 | 54 | 173 | 3 | EFO_0022244 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 4.37e-03 | 56 | 173 | 3 | EFO_0022250 | |
| Disease | sucrose measurement | 4.39e-03 | 17 | 173 | 2 | EFO_0010535 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 4.39e-03 | 17 | 173 | 2 | EFO_0022232 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVGVWDNYCVKKQLL | 491 | P40227 | |
| CDYTLEKFASSQKAW | 41 | Q9NP99 | |
| FESLKSDFNKYWVPC | 171 | Q8NFU0 | |
| DWQNCSLKFSSLKYT | 161 | Q07001 | |
| DCYILDQSGTKIYVW | 281 | O75366 | |
| WGEVKLISNCSKFYG | 486 | P05156 | |
| KGWKNYCSQKSLNEA | 206 | Q9NP73 | |
| CQYIWGTKAAGSDKF | 611 | O75077 | |
| VLFEKWFYCKDLGTQ | 126 | P46952 | |
| TWKDFVNNYLSKGVV | 171 | Q9Y4W6 | |
| QASGVWFAKKITQDY | 186 | P15085 | |
| PQNYGTFTCWLKLDK | 321 | Q86SQ3 | |
| DRQCKYIWGQKVTAS | 551 | Q9P0K1 | |
| WVFSNATCKLLKGIY | 111 | P51684 | |
| NVWVGYDNIKSFDIK | 331 | Q9BZP6 | |
| WCQKKTQGYANIDIT | 971 | Q5M775 | |
| ALLKWCQKKTEGYQN | 1016 | Q69YQ0 | |
| WKSEFYANEACKRLQ | 391 | P49753 | |
| KTAAYWCQSVTELKA | 616 | Q12882 | |
| IIDGTWSQAKDIFYK | 176 | Q8NBA8 | |
| YTFCPKANQWEKTDI | 36 | Q9NPI6 | |
| CQWFVKEALLTYKSD | 206 | Q8N4T0 | |
| VYTCTAQGIWKNEQK | 426 | P00736 | |
| TYVQKCWKDVRVGDF | 161 | O94823 | |
| LYDANTQCKWQFGEK | 511 | Q8TE57 | |
| DLTWCGEFNTSKINY | 156 | P28907 | |
| WKISKINSNYEFCDT | 246 | Q13613 | |
| IVKKSCYPRWNETFE | 171 | O43374 | |
| LWNTLGVCKYTVQDE | 131 | P63244 | |
| IVKKSCYPRWNETFE | 171 | C9J798 | |
| CWQVFVTSSGKYNEL | 351 | Q5JSJ4 | |
| ELQEWYKGFLKDCPT | 26 | P84074 | |
| KSWYQKLLAALQFCA | 806 | O75747 | |
| ILGKTNQEYCDWIKR | 201 | Q5VVQ6 | |
| VYTNLCKFTEWIEKT | 236 | Q9Y5K2 | |
| SIKWCKNSYSADVVN | 621 | P56975 | |
| ALCQPSEYSKWKFTN | 861 | P35228 | |
| ASILKSIWYKFQCAD | 411 | Q9Y5S8 | |
| NKVCYQLVFSSWVTG | 136 | A6NIJ9 | |
| FDCTGFWVKDKYKLQ | 311 | P19113 | |
| QFFICTAKTEWLDGK | 111 | A0A0B4J2A2 | |
| DTTYQNLWDAFKAVC | 281 | O00370 | |
| YWESCSQEQEVKQGK | 81 | Q9HBL8 | |
| EVQQWYKGFIKDCPS | 26 | P62166 | |
| NNKSDIWALGCVLYE | 181 | Q96PY6 | |
| ELCQGVKYNFKSDIW | 221 | Q8TD19 | |
| VKYNFKSDIWAVGCV | 226 | Q8TD19 | |
| WGKKCLFTHNIYLQD | 91 | Q4G1C9 | |
| AEYQGKLCVIDWKTS | 241 | Q9BQP7 | |
| TKKQVSVWCSNDYLG | 241 | P13196 | |
| QYDLWGKLICSNFKI | 61 | Q9NXD2 | |
| YRFCTAEGLWLQKDN | 101 | P43220 | |
| KNQCWKSLFIDTYSD | 71 | Q9UK99 | |
| ICVDWKKGSQATYTQ | 121 | P54315 | |
| WSDRKAIQKLYGSCE | 316 | Q8N119 | |
| LEQKVYFKGQCLEEW | 76 | O43924 | |
| WCKYNENLLVTGAVD | 206 | O00628 | |
| ELQEWYKGFLKDCPT | 26 | P37235 | |
| AIYQLSCKWSFGKVF | 76 | P25021 | |
| GKEKSQLCFSWLQYE | 726 | Q9H7Z3 | |
| NQKSDIWALGCVLYE | 181 | Q86SG6 | |
| STEYGLFQISNKLWC | 66 | P00709 | |
| FCYLLVNESNSWDKA | 371 | O60449 | |
| AQNTYAVSWFKGKEL | 156 | Q9H3U5 | |
| EQIYNADETGLFWKC | 171 | Q9Y4A0 | |
| LAACYGLISFKIWQN | 216 | P30559 | |
| QSFCTQKNFAWKEEY | 156 | Q5F1R6 | |
| NGTCYLEFWKDQLAI | 166 | O15529 | |
| KYVELLKTQWTEFNG | 201 | Q9NUU6 | |
| TVTDFKQTVNKGYWF | 221 | P41217 | |
| FYKLQEDCKTIWQES | 41 | P51178 | |
| WYKDCNEIKGERFTV | 161 | Q9HB29 | |
| QFFICTAKTEWLDGK | 111 | P0DN37 | |
| NCSLKFGSWTYDKAE | 171 | Q15825 | |
| SKDYWIAKGSALLCQ | 4141 | Q9C0G6 | |
| YIQEAKAKGLVIFCW | 571 | Q9NPB8 | |
| TVLCQSEWLKYQGKC | 111 | Q9NZS2 | |
| QQGAAYKTFSWLKCV | 696 | Q9Y4C1 | |
| YQMCQDAENGIWFKK | 696 | P20023 | |
| NLLVKEACKFYSSQW | 106 | Q96BY6 | |
| WVDEVGKFCSREYLN | 1341 | O14981 | |
| FLTDKLYWCDAKQSV | 651 | P01133 | |
| NEKWLSIAYGRCQKI | 96 | A2RUU4 | |
| WLYQLSKGELVTNCF | 581 | Q13616 | |
| NFEISYKIWQCGGKL | 416 | Q86SF2 | |
| LAKKYDQWTISKACG | 61 | Q5T5S1 | |
| CFEKDKYILQGVTSW | 1996 | P08519 | |
| NLCPKEKNYEWSFIQ | 996 | Q5VV63 | |
| GNFYTSQILWKKIEA | 141 | Q68D51 | |
| NTFYSWLEGLCVEKR | 231 | Q96HE7 | |
| KCLWTYEIQFSQDGK | 576 | P35475 | |
| LKQYVETHWCAQSEK | 81 | Q96P70 | |
| EYWEENFNCKLTISG | 366 | Q14831 | |
| QSGKTWQDCEYKDAA | 86 | P01042 | |
| SAECAKYWGEIISQQ | 901 | P14735 | |
| TVVHQDWLNGKEYKC | 186 | P01859 | |
| QDWLNGKEYKCKVSN | 241 | P01860 | |
| QDWLNGKEYKCKVSN | 191 | P01861 | |
| QLVSGNWYVKKCLND | 16 | Q9BYW3 | |
| SETAGKWVLCNYDFQ | 476 | Q8TE68 | |
| KYCSQLKDSQWDSVL | 931 | Q86UP8 | |
| KYCSQLKDSQWDSVL | 931 | Q6EKJ0 | |
| IIGDYNWTNLTIKCD | 551 | P54803 | |
| ELTKWYSQCVIQKTG | 676 | Q7Z3Z3 | |
| LQCLEKLYGDKWNSF | 106 | O14772 | |
| YGVKNSEWIDACINI | 66 | P15260 | |
| KAKIQDSLYCAAGAW | 81 | Q93100 | |
| WRISNINEKYKLCGS | 176 | Q13615 | |
| KNCADVKGIRWSVYL | 96 | Q8WXA2 | |
| RSTGFLKWKDYNCDA | 151 | Q6UW15 | |
| DELSSCGWNKKEKYS | 71 | Q86X27 | |
| CLDYKDQTASWKLNF | 256 | P32243 | |
| ITLYACDSKSEFQKW | 86 | P22897 | |
| GATCEKSNYNLFIEW | 1311 | Q13233 | |
| DLCKTQIYTEEGKVW | 31 | Q9Y2I2 | |
| LKCGTWYKFTLTAQN | 1441 | O60469 | |
| RNTNYDVFEKICWGL | 171 | P82914 | |
| VIKFSTDEGQCWQTY | 546 | Q99523 | |
| SGWKYDSCKKNFLIQ | 621 | Q68CJ6 | |
| DAGVWDNYCVKKQLL | 491 | Q92526 | |
| QFFICTAKTEWLDGK | 111 | P62937 | |
| FSDKCKALTQWIAEY | 3821 | Q8NF91 | |
| SCLFKYKSEDQWNRV | 1786 | B5MCY1 | |
| CSGDVLAKKYARWFQ | 41 | P01718 | |
| WKVFLEFCKENGGYT | 931 | Q9HCE1 | |
| LASVYVQWKKFGNAE | 991 | Q7Z494 | |
| GKDYCNFVFKDWVQL | 646 | Q13393 | |
| FCEHSGNKLWKNSVY | 681 | Q8NE09 | |
| QVSLYGKSWDLNKIC | 146 | Q9Y6C5 | |
| KYWEVCSFNEVLASK | 641 | Q9UPR0 | |
| ICAIDYTWNLLKAGK | 241 | Q05209 | |
| GELYWTKVKVNFDNV | 1391 | Q14524 | |
| LKVSCKAWNIYGSQS | 406 | O15389 | |
| SYLNFTKIVEWNGKT | 221 | Q14108 | |
| KGRWTCTEFYEKENA | 421 | Q15714 | |
| YLVDNLWDCAGTQLK | 161 | P0CL83 | |
| CFEKDKYILQGVTSW | 766 | P00747 | |
| SSEVENCKVGLRKWY | 191 | Q8N9S9 | |
| NDQKWYVISSCIGSF | 206 | P08913 | |
| TVTYKNVKFNVWDVG | 51 | P62330 | |
| EKTNGSFLWCEVEKY | 216 | Q8N3C0 | |
| FESSCPQQWIKYFDK | 86 | Q5JTJ3 | |
| QKEGWCKLAFYLLAF | 116 | O95406 | |
| EQIYGADQTGLFWKC | 171 | Q4W5G0 | |
| NCKTTLGWKYEHAFE | 81 | O60688 | |
| CWTTTQGKIFQCNKY | 136 | A8MXY4 | |
| KSYKWEECGKDFNQS | 511 | Q8IYN0 | |
| FGLGVRKWCQYQKEI | 536 | P40200 | |
| VKKFTLYVGDNWNKC | 796 | Q9NZQ8 | |
| WQKQTSEGLAEYCTL | 946 | Q13905 | |
| AYQQCKEGAALWTVL | 546 | Q8N271 | |
| WDLFACNYKLLKTGI | 706 | Q8N3U4 | |
| KYNTCVNATDKWAFT | 891 | O95271 | |
| FINCAYVKWGTLVQD | 171 | Q9UM01 | |
| CGKDFVWYTDLNQQK | 606 | Q8TF20 | |
| LDCFQSEWYELIQKG | 126 | Q8N0X2 | |
| GLDKLSDVFQQWKYC | 341 | Q8TBP0 | |
| DQCLKLTYISEGWEN | 306 | Q8IV45 | |
| ELCNSWGTYFKAVDL | 51 | Q6P2S7 | |
| KSYDLECSTLGKNWK | 126 | Q6ECI4 | |
| KLCKASTYINWEDNS | 326 | P21359 | |
| CFSIGITFYNKWLTK | 26 | Q9NQQ7 | |
| IFQSEQGKKTIDIYW | 821 | P55017 | |
| LIKYNACVNATDKWA | 731 | Q9H2K2 | |
| SWKGCVQTLVEKYSN | 121 | Q9Y5L0 | |
| NCKTTLGWKYEHAFE | 81 | Q96QA6 | |
| LSVKKLRCNQDYTGW | 311 | Q86T82 | |
| CGKGKWYKFNDTVIE | 1981 | Q9UPU5 | |
| LWCNEKGKSFYSTEA | 306 | Q969S3 | |
| YQECGKAFKWSSNLT | 186 | Q9NSJ1 | |
| LSEYNAFWKCVQAGV | 26 | Q9BVK8 | |
| VAEVYKKVWCTTNEG | 4421 | Q5T4S7 | |
| FVLSENFVKSEWCKY | 701 | O60603 | |
| YDGRWKQKLQTSVDF | 1016 | P40818 | |
| VQCDLDLYKSLQAWK | 611 | Q8IWU5 | |
| KDTVCSSQEWVAKYG | 856 | A6NCI4 | |
| SIKYNIWCSTEHGNK | 426 | Q9Y5A9 | |
| VWCISGTNKVYFKQL | 241 | A6NP61 | |
| QKNEKNGICEEAYSW | 686 | Q9Y2L8 | |
| NCKTTLGWKYEQAFE | 81 | P61236 | |
| EFQCQDGKCISYKWV | 31 | P01130 | |
| WGETCEFNIAKSLVY | 5366 | Q9UKN1 | |
| YENKIKGKWSETPCF | 281 | P20929 |